| Current Price | $259.14 | Mkt Cap | $147.4B |
|---|---|---|---|
| Open | $254.84 | P/E Ratio | 20.65 |
| Prev. Close | $255.97 | Div. (Yield) | $7.04 (2.8%) |
| Daily Range | $254.84 - $260.36 | Volume | 1,579,340 |
| 52-Wk Range | $210.28 - $276.69 | Avg. Daily Vol. | 2,741,932 |
A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.
| Current Price | $259.14 | Mkt Cap | $147.4B |
|---|---|---|---|
| Open | $254.84 | P/E Ratio | 20.65 |
| Prev. Close | $255.97 | Div. (Yield) | $7.04 (2.8%) |
| Daily Range | $254.84 - $260.36 | Volume | 1,579,340 |
| 52-Wk Range | $210.28 - $276.69 | Avg. Daily Vol. | 2,741,932 |
The best Bull and Bear pitches based on recency and number of recommendations.
Terrific company and has a game changing migraine drug in early monetization stage. Trading near December lows now and is too darn cheap
Read the most recent pitches from players about AMGN.
Recs
cwardfs
(< 20)
Submitted: 3/5/2021 7:37:24 PM :
Start Price:
$227.13
NASDAQ:AMGN Score:
+6.51
The medical field will have a promising change for human kind.
Recs
Kona2018
(20.62)
Submitted: 2/21/2021 5:36:20 PM :
Start Price:
$232.01
NASDAQ:AMGN Score:
+5.21
Industry leader
Recs
TMFjbonefish
(45.88)
Submitted: 1/12/2021 7:20:54 PM :
Start Price:
$237.12
NASDAQ:AMGN Score:
+0.45
Stable of products can withstand generics while they keep paying a rising dividend.
Find the members with the highest scoring picks in AMGN.
Gardere (< 20) Score: +493.59
The Score Leader is the player with the highest score across all their picks in AMGN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Gardere | < 20 | 3/20/2008 |
|
NS | $31.59 | +720.41% | +226.82% | +493.59 | 0 Comment | |
|
golfdynamo | < 20 | 3/24/2008 |
|
NS | $31.90 | +712.23% | +220.63% | +491.60 | 0 Comment |
| bappy29 | < 20 | 3/24/2008 |
|
3W | $31.90 | +712.23% | +220.63% | +491.60 | 1 Comment | |
| gokulesh | < 20 | 3/24/2008 |
|
3Y | $31.90 | +712.23% | +220.63% | +491.60 | 0 Comment | |
| RyWoods | 59.53 | 3/24/2008 |
|
3Y | $31.90 | +712.23% | +220.63% | +491.60 | 0 Comment | |
| dhcrosse | 83.62 | 3/24/2008 |
|
1Y | $31.90 | +712.23% | +220.63% | +491.60 | 0 Comment | |
| KarenSmart | < 20 | 3/24/2008 |
|
NS | $31.90 | +712.23% | +220.63% | +491.60 | 0 Comment | |
| jchrismc | < 20 | 3/24/2008 |
|
1Y | $31.90 | +712.23% | +220.63% | +491.60 | 0 Comment | |
| GFunkmeister | < 20 | 3/26/2008 |
|
3W | $32.36 | +700.81% | +217.90% | +482.92 | 0 Comment | |
| kerrdog65 | 28.78 | 3/26/2008 |
|
1Y | $32.36 | +700.81% | +217.90% | +482.92 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
